IBDEI195 ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22187,1,4,0)
 ;;=4^780.99
 ;;^UTILITY(U,$J,358.3,22187,1,5,0)
 ;;=5^Cold Intolerance
 ;;^UTILITY(U,$J,358.3,22187,2)
 ;;=Cold Intolerance^328568
 ;;^UTILITY(U,$J,358.3,22188,0)
 ;;=255.41^^125^1388^1
 ;;^UTILITY(U,$J,358.3,22188,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22188,1,4,0)
 ;;=4^255.41
 ;;^UTILITY(U,$J,358.3,22188,1,5,0)
 ;;=5^Adrenal Insuff
 ;;^UTILITY(U,$J,358.3,22188,2)
 ;;=^335240
 ;;^UTILITY(U,$J,358.3,22189,0)
 ;;=249.00^^125^1388^49
 ;;^UTILITY(U,$J,358.3,22189,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22189,1,4,0)
 ;;=4^249.00
 ;;^UTILITY(U,$J,358.3,22189,1,5,0)
 ;;=5^Secondary DM w/o Complication
 ;;^UTILITY(U,$J,358.3,22189,2)
 ;;=^336728
 ;;^UTILITY(U,$J,358.3,22190,0)
 ;;=249.40^^125^1388^48
 ;;^UTILITY(U,$J,358.3,22190,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22190,1,4,0)
 ;;=4^249.40
 ;;^UTILITY(U,$J,358.3,22190,1,5,0)
 ;;=5^Secondary DM w/ Renal Complications
 ;;^UTILITY(U,$J,358.3,22190,2)
 ;;=^336732
 ;;^UTILITY(U,$J,358.3,22191,0)
 ;;=249.60^^125^1388^47
 ;;^UTILITY(U,$J,358.3,22191,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22191,1,4,0)
 ;;=4^249.60
 ;;^UTILITY(U,$J,358.3,22191,1,5,0)
 ;;=5^Secondary DM w/ Neuro Complications
 ;;^UTILITY(U,$J,358.3,22191,2)
 ;;=^336734
 ;;^UTILITY(U,$J,358.3,22192,0)
 ;;=257.2^^125^1388^31
 ;;^UTILITY(U,$J,358.3,22192,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22192,1,4,0)
 ;;=4^257.2
 ;;^UTILITY(U,$J,358.3,22192,1,5,0)
 ;;=5^Hypogonadism
 ;;^UTILITY(U,$J,358.3,22192,2)
 ;;=^88213
 ;;^UTILITY(U,$J,358.3,22193,0)
 ;;=255.42^^125^1388^38
 ;;^UTILITY(U,$J,358.3,22193,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22193,1,4,0)
 ;;=4^255.42
 ;;^UTILITY(U,$J,358.3,22193,1,5,0)
 ;;=5^Mineralcorticoid Deficient
 ;;^UTILITY(U,$J,358.3,22193,2)
 ;;=^335241
 ;;^UTILITY(U,$J,358.3,22194,0)
 ;;=259.50^^125^1388^2
 ;;^UTILITY(U,$J,358.3,22194,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22194,1,4,0)
 ;;=4^259.50
 ;;^UTILITY(U,$J,358.3,22194,1,5,0)
 ;;=5^Androgen Insensitivity,Unspec
 ;;^UTILITY(U,$J,358.3,22194,2)
 ;;=^336738
 ;;^UTILITY(U,$J,358.3,22195,0)
 ;;=275.5^^125^1388^18
 ;;^UTILITY(U,$J,358.3,22195,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22195,1,4,0)
 ;;=4^275.5
 ;;^UTILITY(U,$J,358.3,22195,1,5,0)
 ;;=5^Hungry Bone Syndrome
 ;;^UTILITY(U,$J,358.3,22195,2)
 ;;=^336538
 ;;^UTILITY(U,$J,358.3,22196,0)
 ;;=793.2^^125^1389^3
 ;;^UTILITY(U,$J,358.3,22196,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22196,1,4,0)
 ;;=4^793.2
 ;;^UTILITY(U,$J,358.3,22196,1,5,0)
 ;;=5^Abnormal Chest x-ray, other
 ;;^UTILITY(U,$J,358.3,22196,2)
 ;;=^273419
 ;;^UTILITY(U,$J,358.3,22197,0)
 ;;=277.6^^125^1389^5
 ;;^UTILITY(U,$J,358.3,22197,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22197,1,4,0)
 ;;=4^277.6
 ;;^UTILITY(U,$J,358.3,22197,1,5,0)
 ;;=5^Alpha-1 antitrypsin deficiency
 ;;^UTILITY(U,$J,358.3,22197,2)
 ;;=^87463
 ;;^UTILITY(U,$J,358.3,22198,0)
 ;;=493.92^^125^1389^6
 ;;^UTILITY(U,$J,358.3,22198,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22198,1,4,0)
 ;;=4^493.92
 ;;^UTILITY(U,$J,358.3,22198,1,5,0)
 ;;=5^Asthma, Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,22198,2)
 ;;=^322001
 ;;^UTILITY(U,$J,358.3,22199,0)
 ;;=493.20^^125^1389^11
 ;;^UTILITY(U,$J,358.3,22199,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22199,1,4,0)
 ;;=4^493.20
 ;;^UTILITY(U,$J,358.3,22199,1,5,0)
 ;;=5^COPD with Asthma
 ;;^UTILITY(U,$J,358.3,22199,2)
 ;;=COPD with Asthma^269964
 ;;^UTILITY(U,$J,358.3,22200,0)
 ;;=493.91^^125^1389^7
 ;;^UTILITY(U,$J,358.3,22200,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22200,1,4,0)
 ;;=4^493.91
 ;;^UTILITY(U,$J,358.3,22200,1,5,0)
 ;;=5^Asthma, with Status Asthmat
 ;;
 ;;$END ROU IBDEI195
